Emcure Pharmaceuticals Earnings Per Share vs. Book Value Per Share
| EMCURE Stock | 1,387 14.35 1.05% |
For Emcure Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Emcure Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Emcure Pharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Emcure Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Emcure Pharmaceuticals over time as well as its relative position and ranking within its peers.
Emcure |
Emcure Pharmaceuticals Book Value Per Share vs. Earnings Per Share Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Emcure Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Emcure Pharmaceuticals value to that of its competitors to determine the firm's financial worth. Emcure Pharmaceuticals is one of the top stocks in earnings per share category among its peers. It also is one of the top stocks in book value per share category among its peers creating about 6.18 of Book Value Per Share per Earnings Per Share. Comparative valuation analysis is a catch-all model that can be used if you cannot value Emcure Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Emcure Pharmaceuticals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Emcure Book Value Per Share vs. Earnings Per Share
Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Emcure Pharmaceuticals |
| = | 26.38 X |
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Emcure Pharmaceuticals |
| = | 162.97 X |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Emcure Book Value Per Share Comparison
Emcure Pharmaceuticals is currently under evaluation in book value per share category among its peers.
Emcure Pharmaceuticals Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Emcure Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Emcure Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Emcure Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Emcure Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Emcure Pharmaceuticals is entity of India. It is traded as Stock on NSE exchange.
Emcure Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Emcure Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Emcure Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Emcure Pharmaceuticals' important profitability drivers and their relationship over time.
Use Emcure Pharmaceuticals in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Emcure Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emcure Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Emcure Pharmaceuticals Pair Trading
Emcure Pharmaceuticals Pair Trading Analysis
The ability to find closely correlated positions to Emcure Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Emcure Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Emcure Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Emcure Pharmaceuticals to buy it.
The correlation of Emcure Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Emcure Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Emcure Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Emcure Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Emcure Pharmaceuticals position
In addition to having Emcure Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Developed Markets Basket ETFs Thematic Idea Now
Developed Markets Basket ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Developed Markets Basket ETFs theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Developed Markets Basket ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Emcure Stock
To fully project Emcure Pharmaceuticals' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Emcure Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Emcure Pharmaceuticals' income statement, its balance sheet, and the statement of cash flows.